Obesity induced a leptin-Notch signaling axis in breast cancer

Monica Battle, Corey Gillespie, Alexander Quarshie, Viola Lanier, Tia Harmon, Kaamilah Wilson, Marta Torroella-Kouri, Ruben R. Gonzalez-Perez

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

To investigate whether obesity induces a leptin-Notch signaling axis in breast cancer (BC), leptin-induced Notch was determined in human MCF-7 and MDA-MB231 and mouse E0771 cells and in E0771-BC hosted by syngeneic lean and diet-induced obesity (DIO) C57BL/6J female mice. Lean and DIO mice were treated for 3 weeks with leptin inhibitor (PEG-LPrA2) 1 week after the inoculation of E0771 cells. Leptin induced Notch1, 3 and 4 in BC cells, but Notch2 expression showed opposite pattern in MCF-7 compared to MDA-MB231 cells. Notch loss-of-function (DAPT and dominant negative [R218H] RBP-Jk [CSL/CBF1]) showed that a functional leptin-Notch signaling axis was involved in the proliferation and migration of E0771 cells. E0771-BC onset was affected by obesity (lean mice7/10 [70%] vs. DIO mice: 11/12 [92%]; Pearson χ2: p = 0.06]). PEG-LPrA2 significantly reduced BC growth (untreated: 19/42; [45%] vs. treated: 8/42 [19%]; Pearson χ2: p = 0.008). PEG-LPrA2 did not influence the caloric intake of mice but increased carcass and/or body weights of lean and DIO mice inoculated with E0771 cells, which could be related to the improvement of health conditions (less aggressive disease). Importantly, BC from obese mice had higher levels of Notch3, JAG1 and survivin than lean mice. Inhibition of leptin signaling reduced protein levels of Notch (NICD1, NICD4, Notch3, JAG1 and survivin) and significantly decreased mRNA expression of Notch receptors, ligands and targets. PEG-LPrA's effects were more prominent in DIO mice. Present data suggest that leptin induces Notch, which could be involved in the reported higher incidence and aggressiveness and, poor prognosis of BC in obese patients. What's new? Obesity is known to increase the risk of several types of cancer, including breast cancer (BC). The molecular mechanisms are not well understood, however. In our study, the authors found that the hormone leptin, which is elevated in obesity, may be linked to an increase in Notch signaling. Notch expression in BC is associated with angiogenesis, proliferation, more aggressive tumors and poor prognosis. Targeting the leptin-Notch axis may therefore provide valuable therapeutic and preventive strategies in BC, which would be especially relevant for obese patients at risk.

Original languageEnglish
Pages (from-to)1605-1616
Number of pages12
JournalInternational Journal of Cancer
Volume134
Issue number7
DOIs
StatePublished - Apr 1 2014

Fingerprint

Leptin
Obesity
Breast Neoplasms
Diet
Notch Receptors
Obese Mice
Energy Intake
Cell Movement
Body Weight
Hormones
Ligands
Messenger RNA

Keywords

  • breast cancer, obesity, leptin, notch
  • dominant negative RBP-Jk
  • E0771 cells
  • high-fat diet
  • PEG-LPrA2

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Battle, M., Gillespie, C., Quarshie, A., Lanier, V., Harmon, T., Wilson, K., ... Gonzalez-Perez, R. R. (2014). Obesity induced a leptin-Notch signaling axis in breast cancer. International Journal of Cancer, 134(7), 1605-1616. https://doi.org/10.1002/ijc.28496

Obesity induced a leptin-Notch signaling axis in breast cancer. / Battle, Monica; Gillespie, Corey; Quarshie, Alexander; Lanier, Viola; Harmon, Tia; Wilson, Kaamilah; Torroella-Kouri, Marta; Gonzalez-Perez, Ruben R.

In: International Journal of Cancer, Vol. 134, No. 7, 01.04.2014, p. 1605-1616.

Research output: Contribution to journalArticle

Battle, M, Gillespie, C, Quarshie, A, Lanier, V, Harmon, T, Wilson, K, Torroella-Kouri, M & Gonzalez-Perez, RR 2014, 'Obesity induced a leptin-Notch signaling axis in breast cancer', International Journal of Cancer, vol. 134, no. 7, pp. 1605-1616. https://doi.org/10.1002/ijc.28496
Battle M, Gillespie C, Quarshie A, Lanier V, Harmon T, Wilson K et al. Obesity induced a leptin-Notch signaling axis in breast cancer. International Journal of Cancer. 2014 Apr 1;134(7):1605-1616. https://doi.org/10.1002/ijc.28496
Battle, Monica ; Gillespie, Corey ; Quarshie, Alexander ; Lanier, Viola ; Harmon, Tia ; Wilson, Kaamilah ; Torroella-Kouri, Marta ; Gonzalez-Perez, Ruben R. / Obesity induced a leptin-Notch signaling axis in breast cancer. In: International Journal of Cancer. 2014 ; Vol. 134, No. 7. pp. 1605-1616.
@article{55bb686030374539b2ba21b566b701f7,
title = "Obesity induced a leptin-Notch signaling axis in breast cancer",
abstract = "To investigate whether obesity induces a leptin-Notch signaling axis in breast cancer (BC), leptin-induced Notch was determined in human MCF-7 and MDA-MB231 and mouse E0771 cells and in E0771-BC hosted by syngeneic lean and diet-induced obesity (DIO) C57BL/6J female mice. Lean and DIO mice were treated for 3 weeks with leptin inhibitor (PEG-LPrA2) 1 week after the inoculation of E0771 cells. Leptin induced Notch1, 3 and 4 in BC cells, but Notch2 expression showed opposite pattern in MCF-7 compared to MDA-MB231 cells. Notch loss-of-function (DAPT and dominant negative [R218H] RBP-Jk [CSL/CBF1]) showed that a functional leptin-Notch signaling axis was involved in the proliferation and migration of E0771 cells. E0771-BC onset was affected by obesity (lean mice7/10 [70{\%}] vs. DIO mice: 11/12 [92{\%}]; Pearson χ2: p = 0.06]). PEG-LPrA2 significantly reduced BC growth (untreated: 19/42; [45{\%}] vs. treated: 8/42 [19{\%}]; Pearson χ2: p = 0.008). PEG-LPrA2 did not influence the caloric intake of mice but increased carcass and/or body weights of lean and DIO mice inoculated with E0771 cells, which could be related to the improvement of health conditions (less aggressive disease). Importantly, BC from obese mice had higher levels of Notch3, JAG1 and survivin than lean mice. Inhibition of leptin signaling reduced protein levels of Notch (NICD1, NICD4, Notch3, JAG1 and survivin) and significantly decreased mRNA expression of Notch receptors, ligands and targets. PEG-LPrA's effects were more prominent in DIO mice. Present data suggest that leptin induces Notch, which could be involved in the reported higher incidence and aggressiveness and, poor prognosis of BC in obese patients. What's new? Obesity is known to increase the risk of several types of cancer, including breast cancer (BC). The molecular mechanisms are not well understood, however. In our study, the authors found that the hormone leptin, which is elevated in obesity, may be linked to an increase in Notch signaling. Notch expression in BC is associated with angiogenesis, proliferation, more aggressive tumors and poor prognosis. Targeting the leptin-Notch axis may therefore provide valuable therapeutic and preventive strategies in BC, which would be especially relevant for obese patients at risk.",
keywords = "breast cancer, obesity, leptin, notch, dominant negative RBP-Jk, E0771 cells, high-fat diet, PEG-LPrA2",
author = "Monica Battle and Corey Gillespie and Alexander Quarshie and Viola Lanier and Tia Harmon and Kaamilah Wilson and Marta Torroella-Kouri and Gonzalez-Perez, {Ruben R.}",
year = "2014",
month = "4",
day = "1",
doi = "10.1002/ijc.28496",
language = "English",
volume = "134",
pages = "1605--1616",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "7",

}

TY - JOUR

T1 - Obesity induced a leptin-Notch signaling axis in breast cancer

AU - Battle, Monica

AU - Gillespie, Corey

AU - Quarshie, Alexander

AU - Lanier, Viola

AU - Harmon, Tia

AU - Wilson, Kaamilah

AU - Torroella-Kouri, Marta

AU - Gonzalez-Perez, Ruben R.

PY - 2014/4/1

Y1 - 2014/4/1

N2 - To investigate whether obesity induces a leptin-Notch signaling axis in breast cancer (BC), leptin-induced Notch was determined in human MCF-7 and MDA-MB231 and mouse E0771 cells and in E0771-BC hosted by syngeneic lean and diet-induced obesity (DIO) C57BL/6J female mice. Lean and DIO mice were treated for 3 weeks with leptin inhibitor (PEG-LPrA2) 1 week after the inoculation of E0771 cells. Leptin induced Notch1, 3 and 4 in BC cells, but Notch2 expression showed opposite pattern in MCF-7 compared to MDA-MB231 cells. Notch loss-of-function (DAPT and dominant negative [R218H] RBP-Jk [CSL/CBF1]) showed that a functional leptin-Notch signaling axis was involved in the proliferation and migration of E0771 cells. E0771-BC onset was affected by obesity (lean mice7/10 [70%] vs. DIO mice: 11/12 [92%]; Pearson χ2: p = 0.06]). PEG-LPrA2 significantly reduced BC growth (untreated: 19/42; [45%] vs. treated: 8/42 [19%]; Pearson χ2: p = 0.008). PEG-LPrA2 did not influence the caloric intake of mice but increased carcass and/or body weights of lean and DIO mice inoculated with E0771 cells, which could be related to the improvement of health conditions (less aggressive disease). Importantly, BC from obese mice had higher levels of Notch3, JAG1 and survivin than lean mice. Inhibition of leptin signaling reduced protein levels of Notch (NICD1, NICD4, Notch3, JAG1 and survivin) and significantly decreased mRNA expression of Notch receptors, ligands and targets. PEG-LPrA's effects were more prominent in DIO mice. Present data suggest that leptin induces Notch, which could be involved in the reported higher incidence and aggressiveness and, poor prognosis of BC in obese patients. What's new? Obesity is known to increase the risk of several types of cancer, including breast cancer (BC). The molecular mechanisms are not well understood, however. In our study, the authors found that the hormone leptin, which is elevated in obesity, may be linked to an increase in Notch signaling. Notch expression in BC is associated with angiogenesis, proliferation, more aggressive tumors and poor prognosis. Targeting the leptin-Notch axis may therefore provide valuable therapeutic and preventive strategies in BC, which would be especially relevant for obese patients at risk.

AB - To investigate whether obesity induces a leptin-Notch signaling axis in breast cancer (BC), leptin-induced Notch was determined in human MCF-7 and MDA-MB231 and mouse E0771 cells and in E0771-BC hosted by syngeneic lean and diet-induced obesity (DIO) C57BL/6J female mice. Lean and DIO mice were treated for 3 weeks with leptin inhibitor (PEG-LPrA2) 1 week after the inoculation of E0771 cells. Leptin induced Notch1, 3 and 4 in BC cells, but Notch2 expression showed opposite pattern in MCF-7 compared to MDA-MB231 cells. Notch loss-of-function (DAPT and dominant negative [R218H] RBP-Jk [CSL/CBF1]) showed that a functional leptin-Notch signaling axis was involved in the proliferation and migration of E0771 cells. E0771-BC onset was affected by obesity (lean mice7/10 [70%] vs. DIO mice: 11/12 [92%]; Pearson χ2: p = 0.06]). PEG-LPrA2 significantly reduced BC growth (untreated: 19/42; [45%] vs. treated: 8/42 [19%]; Pearson χ2: p = 0.008). PEG-LPrA2 did not influence the caloric intake of mice but increased carcass and/or body weights of lean and DIO mice inoculated with E0771 cells, which could be related to the improvement of health conditions (less aggressive disease). Importantly, BC from obese mice had higher levels of Notch3, JAG1 and survivin than lean mice. Inhibition of leptin signaling reduced protein levels of Notch (NICD1, NICD4, Notch3, JAG1 and survivin) and significantly decreased mRNA expression of Notch receptors, ligands and targets. PEG-LPrA's effects were more prominent in DIO mice. Present data suggest that leptin induces Notch, which could be involved in the reported higher incidence and aggressiveness and, poor prognosis of BC in obese patients. What's new? Obesity is known to increase the risk of several types of cancer, including breast cancer (BC). The molecular mechanisms are not well understood, however. In our study, the authors found that the hormone leptin, which is elevated in obesity, may be linked to an increase in Notch signaling. Notch expression in BC is associated with angiogenesis, proliferation, more aggressive tumors and poor prognosis. Targeting the leptin-Notch axis may therefore provide valuable therapeutic and preventive strategies in BC, which would be especially relevant for obese patients at risk.

KW - breast cancer, obesity, leptin, notch

KW - dominant negative RBP-Jk

KW - E0771 cells

KW - high-fat diet

KW - PEG-LPrA2

UR - http://www.scopus.com/inward/record.url?scp=84892615742&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892615742&partnerID=8YFLogxK

U2 - 10.1002/ijc.28496

DO - 10.1002/ijc.28496

M3 - Article

C2 - 24114531

AN - SCOPUS:84892615742

VL - 134

SP - 1605

EP - 1616

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 7

ER -